FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Julia Karbach

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Physiology

Cytotoxicity, Immunologic

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Julia Karbach; Torsten Schubert
Training-induced cognitive and neural plasticity.
Julia Karbach; Markus Maeurer; Antje Neumann; Lloyd J Old; Erika Ritter; Gerd Ritter; Ekkehard Siegel; Takamasa Tsuji; Claudia Wahle; Kathrin Brand; Sacha Gnjatic; Elke Jäger
Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity.
Julia Karbach; Wilfried Wagner; Wiltrud Coerdt; Oliver Bartsch
Case report: Noonan syndrome with multiple giant cell lesions and review of the literature.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Julia Karbach (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Julia Karbach; Torsten Schubert
Training-induced cognitive and neural plasticity.
Frontiers in human neuroscience 2013;7():48.
2012: Julia Karbach; Markus Maeurer; Antje Neumann; Lloyd J Old; Erika Ritter; Gerd Ritter; Ekkehard Siegel; Takamasa Tsuji; Claudia Wahle; Kathrin Brand; Sacha Gnjatic; Elke Jäger
Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(19):5449-59.
2012: Julia Karbach; Wilfried Wagner; Wiltrud Coerdt; Oliver Bartsch
Case report: Noonan syndrome with multiple giant cell lesions and review of the literature.
American journal of medical genetics. Part A 2012;158A(9):2283-9.
2012: Julia Karbach; Antje Neumann; Claudia Wahle; Kathrin Brand; Sacha Gnjatic; Elke Jäger
Therapeutic administration of a synthetic CpG oligodeoxynucleotide triggers formation of anti-CpG antibodies.
Cancer research 2012;72(17):4304-10.
2012: Julia Karbach; Christian Walter; Bilal Al-Nawas
Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation.
Clinical oral investigations 2012;16(4):1305-12.
2012: Jutta Kray; Julia Karbach; Agnès Blaye
The influence of stimulus-set size on developmental changes in cognitive control and conflict adaptation.
Acta psychologica 2012;140(2):119-28.
2011: Anastasia Mouratidou; Bernd d'Hoedt; Julia Karbach; Bilal Al-Nawas
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Journal of periodontology 2011;82(9):1360-6.
2011: Julia Karbach; Jutta Kray; Bernhard Hommel
Action-effect learning in early childhood: does language matter?
Psychological research 2011;75(4):334-40.
2011: Jutta Kray; Susann Haenig; Julia Karbach; Christine Freitag
Can task-switching training enhance executive control functioning in children with attention deficit/-hyperactivity disorder?
Frontiers in human neuroscience 2011;5():180.
2010: Julia Karbach; Sandra Mang; Jutta Kray
Transfer of task-switching training in older age: the role of verbal processes.
Psychology and aging 2010;25(3):677-83.
2010: Antje Neumann; Julia Karbach; Akin Atmaca; Elke Jäger
[Long-term remission of malignant melanoma stage IV after antigen-specific immunotherapy].
Medizinische Klinik (Munich, Germany : 1983) 2010;105(4):273-5.
2010: Julia Karbach; Sacha Gnjatic; Armin Bender; Antje Neumann; Eckhart Weidmann; Jianda Yuan; Cathy A Ferrara; Eric Hoffmann; Lloyd J Old; Nasser K Altorki; Elke Jäger
Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.
International journal of cancer. Journal international du cancer 2010;126(4):909-18.
2009: Julia Karbach; Jutta Kray
How useful is executive control training? Age differences in near and far transfer of task-switching training.
Developmental science 2009;12(6):978-90.
2008: Yuansheng Sun; Mingxia Song; Elke Jäger; Christina Schwer; Stefan Stevanovic; Sven Flindt; Julia Karbach; Xuan D Nguyen; Dirk Schadendorf; Klaus Cichutek
Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(13):4306-15.
2008: Yuriy V Shebzukhov; IN Lavrik; Julia Karbach; Svetlana V Khlgatian; Ekaterina P Koroleva; Pavel V Belousov; Kirill N Kashkin; Alexander Knuth; Elke Jager; Nai-Wen Chi; Dmitry V Kuprash; Sergei A Nedospasov
Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients.
Cancer immunology, immunotherapy : CII 2008;57(6):871-81.
2008: Jutta Kray; Jutta Eber; Julia Karbach
Verbal self-instructions in task switching: a compensatory tool for action-control deficits in childhood and old age?
Developmental science 2008;11(2):223-36.
2007: Julia Karbach; Sacha Gnjatic; Claudia Pauligk; Armin Bender; Markus J Maeurer; Joachim L Schultze; Kerstin Nadler; Claudia Wahle; Alexander Knuth; Lloyd J Old; Elke Jäger
Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination.
International journal of cancer. Journal international du cancer 2007;121(9):2042-8.
2007: Julia Karbach; Serge C Thal; Achim Weber; Erik Springer; Andreas Eich; Ruth Genitsariotis; Bilal Al-Nawas
Swelling of the buccal cheek: an unusual presentation of primary tuberculosis.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2007;65(10):2108-11.
2007: Julia Karbach; Angelika Callaway; Brita Willershausen; W Wagner; Margrit-Ann Geibel; Bilal Al-Nawas
Antibiotic resistance testing of the total implant-associated micro-flora and its pure isolates.
European journal of medical research 2007;12(3):120-8.
2007: Danila Valmori; Frédéric Lévy; Emmanuelle Godefroy; Luigi Scotto; Naira E Souleimanian; Julia Karbach; Valeria Tosello; Charles Hesdorffer; Lloyd J Old; Elke Jager; Maha Ayyoub
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen.
Clinical immunology (Orlando, Fla.) 2007;122(2):163-72.
2007: Armin Bender; Julia Karbach; Antje Neumann; Dirk Jäger; Salah-Eddin Al-Batran; Akin Atmaca; Eckhart Weidmann; Melina Biskamp; Sacha Gnjatic; Linda Pan; Eric Hoffman; Lloyd J Old; Alexander Knuth; Elke Jäger
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
Cancer immunity 2007;7():16.
2006: Elke Jäger; Julia Karbach; Sacha Gnjatic; Antje Neumann; Armin Bender; Danila Valmori; Maha Ayyoub; Erika Ritter; Gerd Ritter; Dirk Jäger; Dennis Panicali; Eric Hoffman; Linda Pan; Herbert Oettgen; Lloyd J Old; Alexander Knuth
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(39):14453-8.
2006: Marco A Purbhoo; Deborah H Sutton; Joanna E Brewer; Rebecca E Mullings; Maxine E Hill; Tara Mahon; Julia Karbach; Elke Jäger; Brian Cameron; Nikolai M Lissin; Paresh Vyas; Ji-Li Chen; Vincenzo Cerundolo; Bent K Jakobsen
Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(12):7308-16.
2006: Julia Karbach; Claudia Pauligk; Armin Bender; Sacha Gnjatic; Kerstin Franzmann; Claudia Wahle; Dirk Jäger; Alexander Knuth; Lloyd J Old; Elke Jäger
Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
International journal of cancer. Journal international du cancer 2006;118(3):668-74.
2005: Yuriy V Shebzukhov; Ekaterina P Koroleva; Svetlana V Khlgatian; Maria A Lagarkova; Andrey A Meshcheryakov; Mikhail R Lichinitser; Julia Karbach; Elke Jager; Dmitry V Kuprash; Sergei A Nedospasov
Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy.
Immunology letters 2005;100(1):88-93.
2005: Salah-Eddin Al-Batran; Mohammad-Reza Rafiyan; Akin Atmaca; Antje Neumann; Julia Karbach; Armin Bender; Eckhart Weidmann; Hans-Michael Altmannsberger; Alexander Knuth; Elke Jäger
Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma.
Cancer research 2005;65(9):3937-41.
2005: Dirk Jäger; Julia Karbach; Claudia Pauligk; Inka Seil; Claudia Frei; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth; Elke Jäger
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
Cancer immunity 2005;5():11.
2004: Eduardo Huarte; Julia Karbach; Sacha Gnjatic; Armin Bender; Dirk Jäger; Michael Arand; Djordje Atanackovic; Jonathan Skipper; Gerd Ritter; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth; Elke Jäger
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.
Cancer immunity 2004;4():15.
2003: Jonathan Cebon; Elke Jäger; Mark Shackleton; Peter Gibbs; Ian D Davis; Wendie Hopkins; Sharen Gibbs; Qiyuan Chen; Julia Karbach; Heather Jackson; Duncan P MacGregor; Sue Sturrock; Hilary A Vaughan; Eugene Maraskovsky; Antje Neumann; Eric Hoffman; Mathew L Sherman; Alexander Knuth
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma.
Cancer immunity 2003;3():7.
2002: Elke Jäger; Julia Karbach; Sacha Gnjatic; Dirk Jäger; Markus J Maeurer; Akin Atmaca; Michael Arand; Jonathan Skipper; Elisabeth Stockert; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
Cancer immunity 2002;2():12.
2002: Dirk Jäger; Elisabeth Stockert; Julia Karbach; Kristina Herrlinger; Akin Atmaca; Michael Arand; Yao-Tseng Chen; Sacha Gnjatic; Lloyd J Old; Alexander Knuth; Elke Jäger
Urine antibody against human cancer antigen NY-ESO-1.
Cancer immunity 2002;2():10.
2002: Elke Jäger; Hanni Höhn; Antje Necker; Reinhold Förster; Julia Karbach; Kirsten Freitag; Claudia Neukirch; Chiara Castelli; Russell D Salter; Alexander Knuth; Markus J Maeurer
Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.
International journal of cancer. Journal international du cancer 2002;98(3):376-88.
2002: Elke Jäger; Russell D Salter; Chiara Castelli; Hanni Höhn; Kirsten Freitag; Julia Karbach; Claudia Neukirch; Antje Necker; Alexander Knuth; Markus J Maeurer
Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(6):2766-72.
2002: Markus J Maeurer; Antje Necker; Russell D Salter; Chiara Castelli; Hanni Höhn; Julia Karbach; Kirsten Freitag; Claudia Neukirch; Alexander Knuth; Elke Jäger
Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue.
International journal of cancer. Journal international du cancer 2002;97(1):64-71.
2001: Mark Ringhoffer; Michael Schmitt; Julia Karbach; Elke Jäger; F Oesch; Michael Arand
Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
International journal of oncology 2001;19(5):983-9.
2001: Dirk Jäger; Elisabeth Stockert; Ali O Güre; Matthew J Scanlan; Julia Karbach; Elke Jäger; Alexander Knuth; Lloyd J Old; Yao-Tseng Chen
Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.
Cancer research 2001;61(5):2055-61.
2000: Elke Jäger; Sacha Gnjatic; Y Nagata; Elisabeth Stockert; Dirk Jäger; Julia Karbach; Antje Neumann; J Rieckenberg; Yao-Tseng Chen; Gerd Ritter; Eric Hoffman; Michael Arand; Lloyd J Old; Alexander Knuth
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(22):12198-203.
2000: Elke Jäger; Markus J Maeurer; Hanni Höhn; Julia Karbach; Dirk Jäger; Z Zidianakis; A Bakhshandeh-Bath; J Orth; Claudia Neukirch; Antje Necker; Torsten E Reichert; Alexander Knuth
Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides.
International journal of cancer. Journal international du cancer 2000;86(4):538-47.
2000: Elke Jäger; Y Nagata; Sacha Gnjatic; H Wada; Elisabeth Stockert; Julia Karbach; P Rod Dunbar; S Y Lee; Achim Jungbluth; Dirk Jäger; Michael Arand; Gerd Ritter; V Cerundolo; Bo Dupont; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(9):4760-5.
2000: Elke Jäger; D Jäger; Julia Karbach; Y T Chen; G Ritter; Y Nagata; Sacha Gnjatic; Elisabeth Stockert; Michael Arand; Lloyd J Old; Alexander Knuth
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.
The Journal of experimental medicine 2000;191(4):625-30.
1999: Elke Jäger; Elisabeth Stockert; Z Zidianakis; Yao-Tseng Chen; Julia Karbach; Dirk Jäger; Michael Arand; Gerd Ritter; Lloyd J Old; Alexander Knuth
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events.
International journal of cancer. Journal international du cancer 1999;84(5):506-10.
1999: Elke Jäger; Hanni Höhn; Julia Karbach; F Momburg; Chiara Castelli; Alexander Knuth; Barbara Seliger; Markus J Maeurer
Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A.
International journal of cancer. Journal international du cancer 1999;81(6):979-84.
1998: Elisabeth Stockert; Elke Jäger; Yao-Tseng Chen; Matthew J Scanlan; Ivan T Gout; Julia Karbach; Michael Arand; Alexander Knuth; Lloyd J Old
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.
The Journal of experimental medicine 1998;187(8):1349-54.
1998: Elke Jäger; Yao-Tseng Chen; J W Drijfhout; Julia Karbach; Mark Ringhoffer; Dirk Jäger; Michael Arand; H Wada; Y Noguchi; Elisabeth Stockert; Lloyd J Old; Alexander Knuth
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.
The Journal of experimental medicine 1998;187(2):265-70.
1998: D Jung; E Jaeger; S Cayeux; Thomas Blankenstein; C Hilmes; Julia Karbach; U Moebius; Alexander Knuth; Christoph Huber; Barbara Seliger
Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes.
Human gene therapy 1998;9(1):53-62.
1997: Elke Jäger; Mark Ringhoffer; M Altmannsberger; Michael Arand; Julia Karbach; Dirk Jäger; F Oesch; Alexander Knuth
Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma.
International journal of cancer. Journal international du cancer 1997;71(2):142-7.
1996: Elke Jäger; Mark Ringhoffer; Michael Arand; Julia Karbach; D Jäger; C Ilsemann; M Hagedorn; F Oesch; Alexander Knuth
Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals.
Melanoma research 1996;6(6):419-25.
1996: Markus J Maeurer; H W Chan; Julia Karbach; Russell D Salter; Alexander Knuth; Michael T Lotze; Walter J Storkus
Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
European journal of immunology 1996;26(11):2613-23.
1996: H Bernhard; Markus J Maeurer; Elke Jäger; Thomas Wölfel; J Schneider; Julia Karbach; Barbara Seliger; Christoph Huber; W S Storkus; Michael T Lotze; K H Meyer zum Büschenfelde; Alexander Knuth
Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma.
Scandinavian journal of immunology 1996;44(3):285-92.
1996: Elke Jäger; Mark Ringhoffer; H P Dienes; Michael Arand; Julia Karbach; D Jäger; C Ilsemann; M Hagedorn; F Oesch; Alexander Knuth
Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo.
International journal of cancer. Journal international du cancer 1996;67(1):54-62.
1996: Elke Jäger; Mark Ringhoffer; Julia Karbach; Michael Arand; F Oesch; Alexander Knuth
Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
International journal of cancer. Journal international du cancer 1996;66(4):470-6.
1996: E Jäeger; H Bernhard; P Romero; Mark Ringhoffer; Michael Arand; Julia Karbach; C Ilsemann; M Hagedorn; Alexander Knuth
Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens.
International journal of cancer. Journal international du cancer 1996;66(2):162-9.
1996: Markus J Maeurer; Susanne M Gollin; Walter J Storkus; William P Swaney; Julia Karbach; D Martin; Chiara Castelli; R Salter; Alexander Knuth; Michael T Lotze
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(4):641-52.
1994: H Bernhard; Julia Karbach; Thomas Wölfel; P Busch; S Störkel; M Stöckle; C Wölfel; Barbara Seliger; Christoph Huber; K H Meyer zum Büschenfelde
Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
International journal of cancer. Journal international du cancer 1994;59(6):837-42.
1994: Alexander Knuth; H Bernhard; Elke Jäger; Thomas Wölfel; Julia Karbach; C Jäggle; W Strittmatter; K H Meyer zum Büschenfelde
Induction of tumour cell lysis by a bispecific antibody recognising epidermal growth factor receptor (EGFR) and CD3.
European journal of cancer (Oxford, England : 1990) 1994;30A(8):1103-7.
1993: H Bernhard; Julia Karbach; W Strittmatter; K H Meyer zum Büschenfelde; Alexander Knuth
Induction of tumor-cell lysis by bi-specific antibody recognizing ganglioside GD2 and T-cell antigen CD3.
International journal of cancer. Journal international du cancer 1993;55(3):465-70.